Medicinal Product Shortages - update - 03 April 2024

Notice type: Advisory

Date: 03/04/2024

This is the HPRA’s latest weekly update on medicines shortages. We publish this information each week to keep patients and healthcare professionals informed of current and resolved shortages.

We recognise that medicine shortages can be challenging for those who rely on medicines for their health and well-being. It is the case that for many medicines supplied in Ireland, there is more than one strength, form, pack size or brand available from different suppliers.

Your doctor or pharmacist will often be able to supply an alternative strength, form or product to ensure continuity of treatment if the medicine you have been taking is unavailable.

Resolved shortages

The following shortages have been resolved and supply has resumed to the Irish market:

Product

Active Ingredient(s)

Amlode 10mg Tablets

PA0711/138/002

Rowex Ltd

Amlodipine

Beclazone 50 micrograms CFC-Free Inhaler Pressurised Inhalation Solution

PA0436/021/009

Norton Waterford

Beclometasone

Budesonide Teva Pharma 1mg/2 ml Nebuliser Suspension

PA0749/207/003

Teva Pharma B.V.

Budesonide

Epilim Syrup 200mg/5ml Oral Solution

PA0540/150/015

Sanofi-Aventis Ireland Limited T/A SANOFI

Sodium valproate

Fixapost 50 micrograms/ml + 5 mg/ml eye drops, solution in single-dose container

PA1107/014/001

Laboratoires Thea

Timolol & latanoprost

Frovex 2.5mg Film Coated Tablets

PA0865/009/001

Menarini International Operations Luxembourg S.A.

Frovatriptan

Intuniv 1mg Prolonged Release Tablets

EU/1/15/1040/002

Takeda Pharmaceuticals International AG Ireland Branch

Guanfacine

Intuniv 2mg Prolonged Release Tablets

EU/1/15/1040/004

Takeda Pharmaceuticals International AG Ireland Branch

Guanfacine

Mirap 30mg Film Coated Tablets

PA0711/062/002

Rowex Ltd

Mirtazapine

Mirap DisTab 30mg Orodispersible

Tablets

PA0711/094/002

Rowex Ltd

Mirtazapine

Mirap DisTab 45mg Orodispersible

Tablets

PA0711/094/003

Rowex Ltd

Mirtazapine

Mometasone 50 microgram/dose Nasal spray, Suspension

PA0711/196/001

Rowex Ltd

Mometasone

Nebol 5mg Tablets

PA0711/120/001

Rowex Ltd

Nebivolol

Vokanamet 150mg/1000mg Film Coated Tablets

EU/1/14/918/011

Janssen-Cilag International NV

Canagliflozin & metformin

Vokanamet 50mg/1000mg Film Coated Tablets

EU/1/14/918/005

Janssen-Cilag International NV

Canagliflozin & metformin

Vokanamet 50mg/850mg Film Coated Tablets 

EU/1/14/918/002

Janssen-Cilag International NV

Canagliflozin & metformin

Zinnat 250mg Film Coated Tablets

PA23311/003/003

Sandoz Pharmaceuticals d.d.

Cefuroxime

Newly notified shortages

The HPRA has been notified of a shortage of the following products:

Product

Active Ingredient(s)

Diclac 75mg Prolonged Release Tablets

PA0711/009/003

Rowex ltd

Diclofenac

Ezetimibe Rowa 10mg Tablets

PA0074/074/001

Rowa Pharmaceuticals Ltd

Ezetimibe

Lexotan 1.5mg Tablets

PA2239/008/001

CHEPLAPHARM Arzneimittel GmbH

Bromazepam

Mirap 15mg Film Coated Tablets

PA0711/062/001

Rowex Ltd

Mirtazapine

Stemetil 12.5mg/ml solution for injection 1ml Ampoule

PA0540/127/002

Sanofi-Aventis Ireland Limited T/A SANOFI

Prochlorperazine

Tobramycin 40mg/ml Solution for Injection

80mg/2ml presentation

PA0822/207/001

Pfizer Healthcare Ireland

Tobramycin

Please see the shortages section of the HPRA website for further information

The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.



« Back